TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether AMG 386 or AMG 386 Placebo in combination
with Paclitaxel and Carboplatin are effective in the treatment of ovarian cancer.